Efficiency of Cytokine-Induced Killer Cells in Combination with Chemotherapy for Triple-Negative Breast Cancer

PURPOSE: The treatment of triple-negative breast cancer (TNBC) remains challenging, due to the absence of estrogen, progesterone, and human epidermal growth factor receptors. This study was designed to evaluate the efficiency and safety of cytokine-induced killer (CIK) cell immunotherapy, following...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Man, Wang, Yang, Wei, Feng, An, Xiumei, Zhang, Naining, Cao, Shui, Ren, Baozhu, Zhang, Xinwei, Ren, Xiubao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015982/
https://www.ncbi.nlm.nih.gov/pubmed/29963110
http://dx.doi.org/10.4048/jbc.2018.21.2.150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015982/
https://www.ncbi.nlm.nih.gov/pubmed/29963110
http://dx.doi.org/10.4048/jbc.2018.21.2.150

Ejemplares similares